GRAND RAPIDS — Drug developer Tetra Discovery Partners Inc. plans to launch a clinical trial later this spring on a potential treatment for an autism spectrum disorder.
An experimental drug under development by Tetra Discovery Partners LLC has the potential to treat traumatic brain injury, according to the results of a pre-clinical trial.
The Western Michigan University Homer Stryker M.D. School of Medicine completed the acquisition of the Southwest Michigan Innovation Center on Jan. 1. The medical school plans to use the Innovation Center to expand its research work.